Who is sponsoring NCT02315664?

NCT02315664 is sponsored by University of British Columbia.

What condition does NCT02315664 study?

NCT02315664 studies Knee Osteoarthritis, Joint Diseases.

Is NCT02315664 still recruiting?

NCT02315664 is currently completed. Last updated 28 October 2019.

Are results published for NCT02315664?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-10-28 · How we verify

NCT02315664

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MONITOR-OA: Using Wearable Activity Trackers to Improve Physical Activity in Knee Osteoarthritis

Completed NA Results posted Last updated 28 October 2019

What this trial tests

NA trial testing Education session, Fitbit Flex, and remote coaching by a PT in Knee Osteoarthritis in 61 participants. Completed in 25 May 2017.

Timeline

2 November 2015

Primary endpoint
17 May 2017

25 May 2017

Quick facts

Lead sponsor	University of British Columbia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	supportive care
Enrollment	61
Start date	2 November 2015
Primary completion	17 May 2017
Estimated completion	25 May 2017
Sites	1 location across Canada

Drugs / interventions tested

Education session, Fitbit Flex, and remote coaching by a PT
Same intervention with a 2 month delay

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Joint Diseases — all drugs for Joint Diseases →

Sponsor

University of British Columbia

Who can join

19 and older, any sex, with Knee Osteoarthritis or Joint Diseases. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Time Spent in Moderate-to-Vigorous Physical Activity (MVPA) Primary · Baseline; 2 months, 4 months and 6 months from baseline

Participants wore a SenseWear Mini accelerometer for 7 days at baseline, and Months 2, 4, and 6. We calculated the average daily time (minutes) spent in MVPA accumulated in bouts. A bout is defined as 10 or more consecutive minutes at the level of 3 or higher METs, with allowance for interruption of up to 1 minute below the threshold.

Baseline

Group	Value	95% CI
Immediate Intervention Group	62.1	± 54.6
Delayed Intervention Group	65.3	± 77.4

2 months

Group	Value	95% CI
Immediate Intervention Group	75.5	± 54.3
Delayed Intervention Group	50.0	± 46.8

4 months

Group	Value	95% CI
Immediate Intervention Group	62.6	± 56.3
Delayed Intervention Group	60.1	± 76.8

6 months

Group	Value	95% CI
Immediate Intervention Group	65.6	± 48.5
Delayed Intervention Group	70.7	± 71.9

Time Spent in Sedentary Behaviors Secondary · Change from baseline in time spent sedentary behaviors at 2 months, 4 months, and 6 months.

We calculated the average daily time spent with an energy expenditure of 1.5 METs or lower, occurring in bouts of 20 minutes or more during waking hours.

Baseline

Group	Value	95% CI
Immediate Intervention Group	464.1	± 137.7
Delayed Intervention Group	497.4	± 200.7

2 months

Group	Value	95% CI
Immediate Intervention Group	437.6	± 133.9
Delayed Intervention Group	503.0	± 160.7

4 months

Group	Value	95% CI
Immediate Intervention Group	505.9	± 167.2
Delayed Intervention Group	508.9	± 189

6 months

Group	Value	95% CI
Immediate Intervention Group	435.8	± 138.8
Delayed Intervention Group	496.0	± 179.5

KOOS - Symptoms Secondary · Baseline; 2 months, 4 months and 6 months from baseline

Symptoms were measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Baseline

Group	Value	95% CI
Immediate Intervention Group	59.8	± 16.1
Delayed Intervention Group	62.9	± 17.2

2 months

Group	Value	95% CI
Immediate Intervention Group	62.6	± 15.6
Delayed Intervention Group	61.7	± 14.5

4 months

Group	Value	95% CI
Immediate Intervention Group	62.4	± 14.7
Delayed Intervention Group	63.4	± 16.7

6 months

Group	Value	95% CI
Immediate Intervention Group	62.1	± 15.3
Delayed Intervention Group	61.4	± 19.8

KOOS - Pain Secondary · Baseline; 2 months, 4 months and 6 months from baseline

Pain was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Baseline

Group	Value	95% CI
Immediate Intervention Group	66.2	± 17.5
Delayed Intervention Group	65.1	± 17.9

2 months

Group	Value	95% CI
Immediate Intervention Group	70.9	± 17
Delayed Intervention Group	64.8	± 14.6

4 months

Group	Value	95% CI
Immediate Intervention Group	67.5	± 15.5
Delayed Intervention Group	66.3	± 15.2

6 months

Group	Value	95% CI
Immediate Intervention Group	68.6	± 17.5
Delayed Intervention Group	66.2	± 16.4

KOOS - Activity of Daily Living Secondary · Baseline; 2 months, 4 months and 6 months from baseline

Activity of Daily Living was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Baseline

Group	Value	95% CI
Immediate Intervention Group	71.8	± 17.5
Delayed Intervention Group	74.1	± 17.6

2 months

Group	Value	95% CI
Immediate Intervention Group	76	± 16.1
Delayed Intervention Group	71	± 16.5

4 months

Group	Value	95% CI
Immediate Intervention Group	76.6	± 17.5
Delayed Intervention Group	75.2	± 17.2

6 months

Group	Value	95% CI
Immediate Intervention Group	75.1	± 15.9
Delayed Intervention Group	73.9	± 15.8

KOOS - Sports & Recreation Secondary · Baseline; 2 months, 4 months and 6 months from baseline

Sports \& Recreation was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Baseline

Group	Value	95% CI
Immediate Intervention Group	47.3	± 26.6
Delayed Intervention Group	52.7	± 27.7

2 months

Group	Value	95% CI
Immediate Intervention Group	49.3	± 24.9
Delayed Intervention Group	47	± 23.3

4 months

Group	Value	95% CI
Immediate Intervention Group	50	± 25.6
Delayed Intervention Group	48.9	± 27.7

6 months

Group	Value	95% CI
Immediate Intervention Group	50.4	± 26.3
Delayed Intervention Group	49.8	± 29.2

KOOS - Quality of Life Secondary · Baseline; 2 months, 4 months and 6 months from baseline

Quality of Life was measured by Knee Injury and OA Outcome Score (KOOS). The KOOS measures knee osteoarthritis disease status and consists of five sub-scales: knee pain, stiffness, daily activity, sports/recreation, and quality of life. Scores range from 0 to 100, with higher being better.

Baseline

Group	Value	95% CI
Immediate Intervention Group	41	± 19.8
Delayed Intervention Group	44.6	± 16.3

2 months

Group	Value	95% CI
Immediate Intervention Group	47.2	± 18.9
Delayed Intervention Group	42.4	± 16.8

4 months

Group	Value	95% CI
Immediate Intervention Group	45.4	± 17.6
Delayed Intervention Group	47.5	± 13.6

6 months

Group	Value	95% CI
Immediate Intervention Group	44.9	± 17.9
Delayed Intervention Group	48.1	± 19.1

Partners in Health Scale Secondary · Baseline; 2 months, 4 months and 6 months from baseline

The Partners in Health Scale is a 12-item measure designed to assess self-efficacy, knowledge of health conditions and treatment, and self-management behaviors such as adopting a healthy lifestyle. Scores range from 0 to 96, with lower being better.

Baseline

Group	Value	95% CI
Immediate Intervention Group	18.4	± 12.6
Delayed Intervention Group	20.5	± 12.8

2 months

Group	Value	95% CI
Immediate Intervention Group	14.9	± 11.4
Delayed Intervention Group	18.3	± 13.7

4 months

Group	Value	95% CI
Immediate Intervention Group	14.3	± 10.1
Delayed Intervention Group	14.9	± 9.6

6 months

Group	Value	95% CI
Immediate Intervention Group	12.9	± 9.2
Delayed Intervention Group	13.1	± 9.2

Sponsor's own description

Physical activity is an essential first-line treatment for patients with knee osteoarthritis (OA). However, a 2013 systematic review found only 13% met the activity recommendation of 150 minutes or more per week. The primary goal of this randomized controlled trail is to assess the efficacy of a physical activity counseling model, involving a group education session, the use of Fitbit Flex (a wireless physical activity tracking device), and online/telephone coaching by a physiotherapist (PT), to improve physical activity and reduce sedentary time in patients with knee OA. Engaging in regular physical activity can have the additional benefit of improving cognitive functioning.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

A Community-Based Physical Activity Counselling Program for People With Knee Osteoarthritis: Feasibility and Preliminary Efficacy of the Track-OA Study.
Li LC, Sayre EC, Xie H, Xie H, et al · · 2017 · cited 53× · PMID 28652228 · DOI 10.2196/mhealth.7863
Efficacy of a Community-Based Technology-Enabled Physical Activity Counseling Program for People With Knee Osteoarthritis: Proof-of-Concept Study.
Li LC, Sayre EC, Xie H, Xie H, et al · · 2018 · cited 49× · PMID 29712630 · DOI 10.2196/jmir.8514
Can we improve cognitive function among adults with osteoarthritis by increasing moderate-to-vigorous physical activity and reducing sedentary behaviour? Secondary analysis of the MONITOR-OA study.
Falck RS, Best JR, Li LC, Chan PCY, et al · · 2018 · cited 16× · PMID 30577819 · DOI 10.1186/s12891-018-2369-z
Experiences of Wearable Technology by Persons with Knee Osteoarthritis Participating in a Physical Activity Counseling Intervention: Qualitative Study Using a Relational Ethics Lens.
Leese J, MacDonald G, Backman CL, Townsend A, et al · · 2021 · cited 9× · PMID 34766912 · DOI 10.2196/30332
Cross-sectional and longitudinal neural predictors of physical activity and sedentary behaviour from a 6-month randomized controlled trial.
Falck RS, Hsu CL, Best JR, Boa Sorte Silva NC, et al · · 2024 · cited 6× · PMID 38195673 · DOI 10.1038/s41598-023-48715-z

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Other University of British Columbia trials

Trials by the same sponsor.

NCT07340970 — Sensory Stimuli During Cesarean Delivery · not yet recruiting
NCT07481201 — Phenylalanine Requirements in the Menstrual Phases · NA · not yet recruiting
NCT07492095 — Leucine Requirements in School-Age Children · NA · not yet recruiting
NCT07429305 — Combined Tibial Nerve Stimulation and Standing for People With SCI · NA · recruiting
NCT07519928 — Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02315664 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of British Columbia
Last refreshed: 28 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02315664.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing

NCT02315664

Quick facts

Drugs / interventions tested

Conditions studied

Sponsor

Who can join

Results — posted to ClinicalTrials.gov

Sponsor's own description

Publications & conference data

Related trials

Other recruiting trials for Knee Osteoarthritis

Other University of British Columbia trials

Verify against primary sources